Nyal Borges, MD
Interventional Cardiology · Charlotte, NCNPI 1790042448
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,527 of the $18,334 with a category attached, or 62.9%. 22 manufacturers reported payments, led by Boston Scientific at 42.0% of the total. 2025 is the largest year on record at $5,045, 6.7 times the $755 reported in 2019.
Across 324 payments — averaging $56.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Shockwave Medical, Inc$4K
- Abiomed$2K
- Medtronic$915
- Teleflex LLC$676
- Stryker$608
- plus $2K from 16 others
Across 52 payments — averaging $223.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$11K
- Abiomed$108
- Eli Lilly Export S.A. Puerto Rico Branch$79
What the payments were for
- Travel & lodging$6,70437%
- Food & beverage$11,52763%
- Education$1021%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 94 | $7,698 |
| Shockwave Medical, Inc | 122 | $4,269 |
| Abiomed | 27 | $2,135 |
| Medtronic(2 entities) | 22 | $915 |
| Teleflex LLC | 6 | $676 |
| Stryker | 9 | $608 |
| Siemens Medical Solutions USA, Inc. | 3 | $472 |
| Verge Medical, Inc. | 1 | $325 |
| Asahi Intecc USA, Inc. | 9 | $317 |
| Philips North America LLC | 3 | $201 |
| E.r. Squibb & Sons, L.L.C. | 4 | $127 |
| AstraZeneca | 2 | $113 |
| Inari Medical, Inc. | 5 | $107 |
| Reflow Medical Inc | 5 | $84 |
| Edwards Lifesciences | 2 | $65 |
| Abbott | 2 | $51 |
| Angiodynamics, Inc. | 2 | $47 |
| Novartis | 2 | $45 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $23 |
| Cathworks, Inc. | 1 | $21 |
| Imperative Care, Inc | 1 | $21 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$2,838
- AVVIGO Guidance System$2,603
- Impella$1,457
- GENERAL - THERAPIES$1,091
- FlowTriever$417
- GUIDELINER$379
- FLASH Ostial System$325
- OPTICROSS$247
- MAMBA$218
- ACUSON Origin Diagnostic Ultrasound System$170
- Vitalyst$169
- Asahi Coronary Wires$165
- GENERAL - STRUCTURAL HEART$164
- Resolute$145
- (6574) Coronary Other$145
- Artis icono floor$138
- CoreValve Evolut$129
- GENERAL - STENTS$126
- SYMPLICITY G3$125
- TWIN-PASS$106
How this compares
$18,334 in reported general payments places this provider in the 75th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 72 | $79,353 |
| Praluent PenAlirocumab | 23 | $27,008 |
| Repatha SureclickEvolocumab | 25 | $22,716 |
| Ranolazine ErRanolazine | 46 | $5,608 |
| ClopidogrelClopidogrel Bisulfate | 323 | $3,856 |
| Ezetimibe | 129 | $2,389 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 102 | $2,111 |
| Atorvastatin Calcium | 167 | $1,746 |
| Metoprolol Succinate | 130 | $1,654 |
| Rosuvastatin Calcium | 60 | $1,018 |
| Losartan Potassium | 79 | $789 |
| Amlodipine Besylate | 74 | $480 |
| Carvedilol | 51 | $413 |
| Spironolactone | 26 | $285 |
| Chlorthalidone | 12 | $230 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Charlotte
- Oluseun AlliCharlotte$485K
- Glen FandettiCharlotte$46K
- John PasquiniCharlotte$32K
- Aamer QureshiCharlotte$27K
- Daniel PuCharlotte$23K
- George AdamsGarner$4.1M
- Paul MahoneyGreenville$1.7M
- Ravish SacharRaleigh$1.6M
- Patrick SimpsonPinehurst$579K
- Ronald UszenskiMooresville$495K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.